Published in Drug Week, July 28th, 2006
At the same time, Medtronic also said it has completed enrollment in two other clinical trials: the RESOLUTE study evaluating the company's next generation DES product and the ENDEAVOR-Japan study evaluating the Endeavor stent at 12 clinical sites in Japan.
The ENDEAVOR IV study is part of an extensive clinical program that also includes the ENDEAVOR I, II and III...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.